Erythrocytes and Blood Typing

What are erythrocytes?

Erythrocytes lack a nucleus.

What is the average lifespan of a red blood cell in circulation?

How many red blood cells are produced per second by the adult bone marrow?

What are the three main functions of erythrocytes?

All human blood contains erythrocytes, leukocytes, and thrombocytes.

What is formed when red blood cells clump together?

What are antigens?

Antigens are also called agglutinogens.

Antibodies are also called agglutinins.

The presence or absence of erythrocyte antigens is determined genetically.

The vast majority of erythrocyte antigens are weak.

What are the three main blood group antigens?

The corresponding antibodies, normally absent if the antigen is present, are designated as ______.

What are the two blood groups that are commonly examined in blood typing?

Which of the following statements is true about blood group A?

Transfusing blood group B into a recipient with blood group B will result in no reaction.

Transfusing blood group A into a recipient with blood group B will not cause a reaction.

Transfusing blood group B into a recipient with blood group O will cause a reaction.

What is the name of the clinical condition that occurs when incompatible blood types are mixed resulting in agglutination?

What are some common symptoms of a transfusion reaction?

Transfusion reactions are only caused by incompatibility in the ABO blood group.

What is another name for the Rh blood group?

The Rh blood group was discovered in 1940.

How is the Rh blood group determined?

The presence or absence of the D antigen determines whether an individual is Rh positive or negative.

Rh-negative individuals have the D antigen on their red blood cells.

Rh-negative individuals have anti-D antibodies in their plasma.

Rh-positive individuals never develop anti-D antibodies.

It is safe to transfuse Rh-positive blood into an Rh-negative recipient.

It is safe to transfuse Rh-negative blood into an Rh-positive recipient.

Rh-positive individuals can safely receive Rh-negative blood.

Rh-negative individuals can safely receive Rh-positive blood.

The Rh blood group is clinically significant.

Anti-D antibodies are typically found in the plasma of Rh-positive individuals.

Rh-negative mothers who have been exposed to Rh-positive blood during pregnancy have a higher risk of developing anti-D antibodies.

Anti-D antibodies can cross the placenta and affect the fetus.

Anti-D antibodies do not pose a risk to the fetus unless the fetus is Rh-positive.

A first Rh-negative pregnancy does not increase the risk of developing anti-D antibodies in the mother.

A second Rh-negative pregnancy increases the risk of developing anti-D antibodies in the mother.

A second Rh-negative pregnancy after an Rh-positive pregnancy carries a higher risk of developing anti-D antibodies in the mother.

Anti-D antibodies can only be developed during pregnancy.

Anti-D antibodies are not harmful during a first pregnancy.

Anti-D antibodies are harmful during a second pregnancy.

There is no way to prevent the development of anti-D antibodies in Rh-negative mothers.

Rh immunoglobulin or RhoGAM is effective at preventing the development of anti-D antibodies in Rh-negative mothers.

RhoGAM can be given to Rh-negative mothers before, during, or after pregnancy.

RhoGAM is a cure for hemolytic disease of the newborn (HDN).

RhoGAM is only effective if given during pregnancy.

RhoGAM is a safe and effective treatment for pregnant Rh-negative women.

Hemolytic disease of the newborn (HDN) is a serious condition.

HDN is caused by the mother's immune system attacking the fetus's red blood cells.

HDN is only a risk for mothers who are Rh-negative and have been exposed to Rh-positive blood.

HDN can be prevented.

HDN is a common condition.

HDN is a treatable condition.

HDN can be fatal.

HDN is often preventable.